Human CD30/TNFRSF8 F(ab')2 (Research Grade Brentuximab Biosimilar) Antibody, Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MAB129FAB21-Each-of-1 | In Stock | ₹ 41,340.50 |
MAB129FAB21 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 41,340.50
GST (18%): ₹ 7,441.29
Total Price: ₹ 48,781.79
Antigen
CD30/TNFRSF8
Classification
Monoclonal
Conjugate
Unconjugated
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS.
Host Species
Human
Purification Method
Protein A or G purified from cell culture supernatant
Regulatory Status
RUO
Gene ID (Entrez)
943
Target Species
Human
Form
Purified
Applications
Flow Cytometry
Clone
Hu8F2
Dilution
Flow Cytometry 0.25 ug/mL
Gene Alias
CD30, CD30 antigen, CD30KI-1, CD30L receptor, cytokine receptor CD30, D1S166EKi-1, Ki-1 antigen, Lymphocyte activation antigen CD30, TNFRSF8, tumor necrosis factor receptor superfamily member 8, tumor necrosis factor receptor superfamily, member 8
Immunogen
Human CD30/TNFRSF8
Quantity
100 μg
Primary or Secondary
Primary
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Content And Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Isotype
IgG1
Related Products
Description
- CD30/TNFRSF8 Monoclonal antibody specifically detects CD30/TNFRSF8 in Human samples
- It is validated for Flow Cytometry